Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1991 23
1992 49
1993 53
1994 57
1995 56
1996 62
1997 74
1998 63
1999 59
2000 63
2001 54
2002 51
2003 68
2004 52
2005 63
2006 56
2007 70
2008 85
2009 72
2010 80
2011 87
2012 78
2013 77
2014 76
2015 72
2016 59
2017 55
2018 55
2019 14
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

1,627 results
Results by year
Filters applied: . Clear all
Page 1
Regulation of apolipoprotein A-I gene expression by the histamine H1 receptor: Requirement for NF-κB.
Haas MJ, et al. Life Sci 2018. PMID 30012475
AIMS: Earlier it had been found by us that apolipoprotein A-I (apo A-I) is suppressed by histamine in HepG2 cells. Histamine has been shown to regulate NF-κB activity, though not in hepatocytes. ...
AIMS: Earlier it had been found by us that apolipoprotein A-I (apo A-I) is suppressed by histamine in HepG2 cells. Histamine has been …
Dysfunctional HDL and atherosclerotic cardiovascular disease
Rosenson RS, et al. Nat Rev Cardiol 2016 - Review. PMID 26323267 Free PMC article.
Factors that impair the availability of functional apolipoproteins or the activities of ABCA1 and ABCG1 could, therefore, strongly influence atherogenesis. ...Understanding the features of dysfunctional HDL or apolipoprotein A-I in clinical practice might lead to new diagnostic and therapeutic approaches to atherosclerosis....
Factors that impair the availability of functional apolipoproteins or the activities of ABCA1 and ABCG1 could, therefore, strongly in …
Overexpression of apolipoprotein A-I alleviates endoplasmic reticulum stress in hepatocytes.
Guo Q, et al. Lipids Health Dis 2017. PMID 28577569 Free PMC article.
Apolipoprotein A-I (apoA-I) accepts cellular free cholesterol and phospholipids transported by ATP-binding cassette transporter A1 to generate nascent high density lipoprotein particles. ...
Apolipoprotein A-I (apoA-I) accepts cellular free cholesterol and phospholipids transported by ATP-binding cassette transporter A1 to
Expression of the C-terminal domain of human apolipoprotein A-I using a chimeric apolipoprotein.
Sallee DE, et al. Protein Expr Purif 2017. PMID 28624493 Free PMC article.
Human apolipoprotein A-I (apoA-I) is the most abundant protein in high-density lipoprotein, an anti-atherogenic lipid-protein complex responsible for reverse cholesterol transport. ...
Human apolipoprotein A-I (apoA-I) is the most abundant protein in high-density lipoprotein, an anti-atherogenic lipid-protein complex …
[Screening and identification of apolipoprotein A-I as a potential marker for hepatoblastoma in children].
Guo LH, et al. Zhongguo Dang Dai Er Ke Za Zhi 2016. PMID 27974108 Chinese. Free article.
This protein was identified as apolipoprotein A-1 (Apo A-I). Real-time PCR and ELISA verified the low mRNA and protein expression of Apo A-I in serum in the HB group and high expression in serum in the normal group. ...
This protein was identified as apolipoprotein A-1 (Apo A-I). Real-time PCR and ELISA verified the low mRNA and protein expression of …
Apolipoprotein A-I(Milano): current perspectives.
Chiesa G and Sirtori CR. Curr Opin Lipidol 2003 - Review. PMID 12642784
The mutant apolipoprotein A-I(Milano) has been associated with a reduced incidence of coronary disease in carriers. Furthermore, recombinant apolipoprotein A-I(Milano) has displayed remarkable atheroprotective activities and the possibility of directly reducing the burden of atherosclerosis in experimental models. ...SUMMARY: Recombinant apolipoprotein A-I(Milano), formulated as synthetic HDL with phospholipids, appears to exert a direct removing effect on arterial cholesterol. ...
The mutant apolipoprotein A-I(Milano) has been associated with a reduced incidence of coronary disease in carriers. Furthermore, reco …
A case report of hereditary apolipoprotein A-I amyloidosis associated with a novel APOA1 mutation and variable phenotype.
Tougaard BG, et al. Eur J Med Genet 2016. PMID 27240838
Apolipoprotein A-I (apo A-I) amyloidosis is a non-AL, non-AA, and non-transthyretin type of amyloidosis associated with mutations in the APOA1 gene inherited in an autosomal dominant fashion. ...
Apolipoprotein A-I (apo A-I) amyloidosis is a non-AL, non-AA, and non-transthyretin type of amyloidosis associated with mutations in
Effects of Disease-Causing Mutations on the Conformation of Human Apolipoprotein A-I in Model Lipoproteins.
Wilson CJ, et al. Biochemistry 2018. PMID 30004693 Free PMC article.
Human apolipoprotein A-I (apoA-I) is the principal HDL protein whose mutations can cause either aberrant lipid metabolism or amyloid disease. ...
Human apolipoprotein A-I (apoA-I) is the principal HDL protein whose mutations can cause either aberrant lipid metabolism or amyloid …
1,627 results
Jump to page
Feedback